Taysha Gene Therapies (TSHA) Shares Issued (2019 - 2026)

Taysha Gene Therapies (TSHA) has 8 years of Shares Issued data on file, last reported at $4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 5.14% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 5.14% YoY), and the FY2025 full-year result was $24.6 million, up 563.83% from the prior year.
• Shares Issued declined to $4.5 million in Q1 2026, from $24.6 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $24.6 million in Q4 2025 to a low of $452007.0 in Q3 2025.
• A 5-year average of $5.0 million and a median of $4.5 million in 2026 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued surged 5291.57% in 2022 and slumped 82.0% in 2025, its largest moves.
• Tracing TSHA's Shares Issued over 5 years: stood at $1.1 million in 2022, then surged by 570.87% to $7.2 million in 2023, then slumped by 48.33% to $3.7 million in 2024, then jumped by 563.83% to $24.6 million in 2025, then plunged by 81.83% to $4.5 million in 2026.
• Business Quant data shows TSHA's Shares Issued at $4.5 million in Q1 2026, $24.6 million in Q4 2025, and $452007.0 in Q3 2025.